Kawanishi, Japan

Haruo Sinbo

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruo Sinbo. Retrieved from https://idiyas.com/inventor/haruo-sinbo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haruo Sinbo: Innovator in Antimicrobial Composition

Introduction

Haruo Sinbo is a notable inventor based in Kawanishi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial agents. His work has led to the creation of a solid cephalosporin derivative that showcases high stability in storage.

Latest Patents

Sinbo holds a patent for a solid cephalosporin salt. This innovative compound is characterized by the formula: ##STR1##, wherein X is chlorine or bromine, and n is a number from zero to 6. The solid cephalosporin derivative is recognized for its high stability and potential use as an active component in antimicrobial compositions. He has 1 patent to his name.

Career Highlights

Haruo Sinbo is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to focus on developing effective antimicrobial solutions that can benefit public health.

Collaborations

Throughout his career, Sinbo has collaborated with esteemed colleagues such as Kazuo Tsukamura and Kenzo Naito. These partnerships have contributed to the advancement of research and innovation in the pharmaceutical industry.

Conclusion

Haruo Sinbo's contributions to the field of antimicrobial compositions highlight his role as an important inventor in the pharmaceutical sector. His innovative work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…